Advocacy intelligence hub — real-time data for patient organizations
Epogen: FDA approved
Treatment of anemia associated with chronic renal failure, including patients on dialysis (end stage renal disesae) and patients not on dialysis
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Epogen
(Epoetin alfa)Orphan drugAmgen, Inc.
12.1 Mechanism of Action Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.
Browse all Pulmonary arterial hypertension associated with congenital heart disease news →
Tara Matise, Ph.D.
Rutgers, The State University of New Jersey
Werner Budts, MD, PhD
Universitaire Ziekenhuizen KU Leuven
Mahrus Rachman, MD
Dr. Soetomo General Hospital
Zhuoming Xu, Ph D
Shanghai Jiao Tong University School of Medicine
Chi Hornik, PharmD
Duke University
📍 DURHAM, NC
HASCOET SEBASTIEN, MD
Centre Chirurgical Marie Lannelongue
View all Pulmonary arterial hypertension associated with congenital heart disease specialists →